Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -792.49
- Piotroski Score 3.00
- Grade Hold
- Symbol (CING)
- Company Cingulate Inc.
- Price $3.65
- Changes Percentage (-4.7%)
- Change -$0.18
- Day Low $3.64
- Day High $3.85
- Year High $152.40
Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/11/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$19.52
- Trailing P/E Ratio -0.04
- Forward P/E Ratio -0.04
- P/E Growth -0.04
- Net Income $-23,534,947
Income Statement
Quarterly
Annual
Latest News of CING
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Xi's Balancing Act on Ukraine Disrupted by Putin-Kim Alliance
China is facing pressure to control its diplomatic allies, Russia and North Korea, amid concerns over escalating tensions. This poses a challenge for President Xi Jinping's efforts to maintain stabili...
By Yahoo! Finance | 11 hours ago -
Utah is embracing its new NHL team. But is the frenzy sustainable?
Salt Lake City has a turbulent hockey history, but fans are embracing the new franchise, hoping for long-term stability. The Utah HC, transplanted from Arizona, is gaining popularity despite initial c...
By The Guardian | 11 hours ago -
Burberry's new CEO faces outlet store and pricing dilemmas
By Helen Reid and Mimosa SpencerLONDON/PARIS (Reuters) - Burberry's new CEO Joshua Schulman faces an uphill task to turn around the British luxury brand whose sales have declined sharply while its...
By Reuters | 16 hours ago
